ObladenM. Necrotizing enterocolitis: 150 years of fruitless search for the cause. Neonatology. 2009;96:203-210.
2.
HomanRStollBCurnsAYoritaKSteinerCSchonbergerL. Necrotising enterocolitis hospitalizations among neonates in the United States. Paediatr Perinat Epidemiol. 2006;20:498-506.
3.
GuilletRStollBCottenC. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2006;117:e137-e142.
4.
HorbarJBadgerGCarpenterJ. Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics. 2002;110:143-151.
5.
ErasmusHLudwig-AuserHPatersonPSunDSankaranK. Enhanced weight gain in preterm infants receiving lactase-treated feeds: a randomized, double-blind, controlled trial. J Pediatr. 2002;141:532-537.
6.
FitzgibbonsSChingYYuD. Mortality of necrotizing enterocolitis expressed by birth weight catagories. J Pediatr Surg. 2009;44:1072-1075.
7.
SchanlerRShulmanRLauC. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk vs preterm formula. Pediatrics. 1999;103:1150-1157.
8.
ArnoldL. The cost-effectiveness of using banked donor milk in the neonatal intensive care unit: prevention of necrotizing enterocolitis. J Hum Lact. 2002;18:172-177.
9.
BoydCQuigleyMBrocklehursP. Donor breast milk versus infant formula for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2007;92:F169-F175.
10.
LucasAColeT. Breast milk and neonatal necrotizing enterocolitis. Lancet. 1990;336:1519-1523.
11.
McGuireWAnthonyM. Donor human milk versus formula for preventing necrotizing enterocolitis in preterm infants: systematic review. Arch Dis Child Fetal Neonatal Ed. 2003;88:F11-F14.
12.
QuigleyMHendersonGAnthonyMMcGuireW. Formula milk versus donor breast milk for feeding preterm or low birth weight infants (review). Cochrane Database Syst Rev. 2007;4:CD002971.
13.
LucasAFewtrellMMorleyR. Randomized outcome trial of human milk fortification and developmental outcome in preterm infants. Am J Clin Nutr. 1996;64:142-151.
14.
SullivanSSchanlerRKimJ. An exclusively human milk based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk based products. J Pediatr. 2010;156:562-567.
15.
NarayanIGuptaJ. Human milk and neonatal infections. Acta Paediatr Scand Suppl. 1989;351:126-130.
16.
KoivusaloAKauppinenHAnttilaA. Intraluminal casein model of nectrotizing enterocolitis for assessment of mucosal destruction, bacterial translocation, and the effects of allopurinol and N-acetycysteine. Pediatr Surg Int. 2002;18:712-717.
17.
BrownESweetA. Preventing necrotizing enterocolitis in neonates. JAMA. 1978;240:2452-2454.
18.
ChuhanMHendersonGMcGuireW. Enteral feeding for very low birth weight infants: reducing the risk of necrotizing enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2008;93:F162-F166.
19.
AndersonDKliegmanR. The relationship of neonatal alimentation practices to the occurrence of endemic necrotizing enterocolitis. Am J Perinatol. 1991;8:62.
20.
RayyisSAmbalavananNWrightL. Randomized trial of “slow” versus “fast” feed advancements on the incidence of NEC in very low birth weight infants. J Pediatr. 1999;134:293-297.
21.
ZieglerEThureenPCarlsonS. Aggressive nutrition of the very low birth weight infant. Clin Perinatol. 2002;29:225-244.
22.
MihatschWvon SchoenaichPFahnenstichH. The significance of gastric residuals in the early enteral feeding advancement of extremely low birth weight infants. Pediatrics. 2002;109:457-459.
23.
NeuJWalkerK. Medical progress necrotizing enterocolitis. N Engl J Med. 2011;364:255-364.
Adams-ChapmanIStollB. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis. 2006;19:290-297.
26.
WardPPazEConneelyO. Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci. 2005;62(22):2540-2548.
27.
HennartPBrasseurDDelogne-DesnoeckJDramaixMRobynC. Lysozyme, lactoferrin, and secretory immunoglobulin A content in breast milk: influence of duration of lactation, nutrition status, prolactin status, and parity of mother. Am J Clin Nutr. 1991;53:323-329.
28.
LeitchEWilcoxM. Elucidation of the antistaphylococcal action of lactoferrin and lysozyme. J Med Microbiol. 1999;48:867-871.
29.
KuipersMde VriesHEikelboomMMeijerDSwartP. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob Agents Chemother. 1999;43:2635-2641.
30.
HasegawaKMotsuchiWTanakaSDosakoS. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn J Med Sci Biol. 1994;47:73-85.
31.
KalmarJArnoldR. Killing of Actinobacillus actinomycetemcomitans by human lactoferrin. Infect Immun. 1988;56:2552-2557.
32.
FarnaudSEvansR. Lactoferrin-a multifunctional protein with antimicrobial properties. Mol Immunol. 2003;40:395-405.
33.
SuzukiYLopezVLonnerdalB. Mammalian lactoferrin receptors: structure and function. Cell Mol Life Sci. 2005;62:2560-2575.
34.
BellamyWTakaseMWakabayashiHKawaseKTomitaM. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol. 1992;73:472-479.
35.
MulliganPWhiteNMonteleoneG. Breast milk lactoferrin regulates gene expression by binding bacterial DNA CpG motifs but not genomic DNA promoters in model intestinal cells. Pediatr Res. 2006;59:656-661.
36.
ShermanM. New concepts of microbial translocation in the neonatal intestine: mechanisms and prevention. Clin Perinatol. 2010;37:565-579.
37.
ManzoniPRinaldiMCattaniS. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low birth weight neonates: a randomized trial. JAMA. 2009;302: 1421-1428.
38.
YamauchiKWakabayashiHShinKTakaseM. Bovine lactoferrin: benefits and mechanism of action against infections. Biochem Cell Biol. 2006;84:291-296.
39.
KaufmanD. Editorial: lactoferrin supplementation to prevent nosocomial infections in preterm infants. JAMA. 2009;302:1421-1428.
40.
Meinzen-DerrJPoindexterBWrageLMorrowAStollBDonovanE. Role of human milk in extremely low birth weight infants’ risk of necrotizing enterocolitis or death. J Perinatol. 2009;29:57-62.
41.
SiskPLoveladyCDillardRGruberJO’SheaT. Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol. 2007;27:428-433.
42.
FanaroffAStollBWrightL. Trends in neonatal morbidity and mortality for very low birth weight infants. Am J Obstet Gynecol. 2007;196:147, e1-e8.
43.
BerluttiFSchippaSMoreaC. Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninvasive Escherichia coli strains. Biochem Cell Biol. 2006;84:351-357.
44.
OtsukiKYakuwaKSawadaM. Recombinant human lactoferrin has preventive effects on lipopolysaccharide-induced preterm delivery and production of inflammatory cytokines in mice. J Perinal Med. 2005;33:320-323.
45.
BuccigrossiVde MarcoGBruzzeseE. Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation. Pediatr Res. 2007;61:410-414.
